Revelation Biosciences's three largest insider shareholders as of August 04, 2026 are George F Tidmarsh (Director, 380.83K shares), James Rolke (Chief Executive Officer, 224.85K shares), Chester Stanley Iii Zygmont (Chief Financial Officer, 105.35K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Capital, Llc Glazer | - | 0 | 95,277 | 23 Sep, 2021 |
| George F Tidmarsh | - | 0 | 380,834 | 08 Feb, 2022 |
| Jess Roper | - | 12,828 | 0 | 05 Feb, 2026 |
| Lakhmir S Chawla | - | 12,158 | 0 | 05 Feb, 2026 |
| Jennifer Carver | - | 12,758 | 0 | 05 Feb, 2026 |
| James Rolke | Chief Executive Officer | 224,853 | 0 | 05 Feb, 2026 |
| Chester Stanley Iii Zygmont | Chief Financial Officer | 0 | 105,348 | 05 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 04 Feb, 2026 | Chester Stanley Iii Zygmont | Common Stock | D | 13,100 | $1.65 | 105,348 | I | F |
| 03 Feb, 2026 | James Rolke | Common Stock | D | 8,521 | $1.86 | 224,853 | D | F |
| 04 Feb, 2026 | Chester Stanley Iii Zygmont | Common Stock | D | 13,100 | $1.65 | 105,348 | I | F |
| 03 Feb, 2026 | Jess Roper | Common Stock | D | 1,591 | $1.85 | 12,828 | D | F |
| 04 Feb, 2026 | Chester Stanley Iii Zygmont | Common Stock | D | 13,100 | $1.65 | 105,348 | I | F |
| 03 Feb, 2026 | Jennifer Carver | Common Stock | D | 1,661 | $1.87 | 12,758 | D | F |
| 03 Feb, 2026 | James Rolke | Common Stock | D | 8,521 | $1.86 | 224,853 | D | F |
| 03 Feb, 2026 | James Rolke | Common Stock | D | 8,521 | $1.86 | 224,853 | D | F |
| 03 Feb, 2026 | Jess Roper | Common Stock | D | 1,591 | $1.85 | 12,828 | D | F |
| 03 Feb, 2026 | Lakhmir S Chawla | Common Stock | D | 2,261 | $1.85 | 12,158 | D | F |
| 03 Feb, 2026 | Jess Roper | Common Stock | D | 1,591 | $1.85 | 12,828 | D | F |
| 08 Jan, 2026 | James Rolke | Common Stock | A | 532,829 | $0.90 | 233,372 | D | A |
| 08 Jan, 2026 | James Rolke | Common Stock | A | 532,829 | $0.90 | 233,372 | D | A |
| 08 Jan, 2026 | Jess Roper | Common Stock | A | 41,981 | $0.90 | 14,417 | D | A |
| 08 Jan, 2026 | Jennifer Carver | Common Stock | A | 41,981 | $0.90 | 14,417 | D | A |
| 08 Jan, 2026 | Jess Roper | Common Stock | A | 41,981 | $0.90 | 14,417 | D | A |
| 08 Jan, 2026 | Jess Roper | Common Stock | A | 41,981 | $0.90 | 14,417 | D | A |
| 08 Jan, 2026 | James Rolke | Common Stock | A | 532,829 | $0.90 | 233,372 | D | A |
| 08 Jan, 2026 | Lakhmir S Chawla | Common Stock | A | 41,981 | $0.90 | 14,417 | D | A |
| 08 Jan, 2026 | Chester Stanley Iii Zygmont | Common Stock | A | 78,145 | $0.90 | 118,448 | I | A |